References
- Alrawashdeh HM. Cataract and healthy diet, an ounce of prevention is worth a pound of cure - a mini-review. J Food Nutr Health. 2020;1(1):1–3. doi:10.47275/2692-5222-105
- Partyka O, Wysocki M. Epidemiology of eye diseases and infrastructure of ophthalmology in Poland. Przegl Epidemiol. 2015;69(4):773–777.
- Office for National Statistics (ONS). Population estimates; 2021. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/datasets/populationestimatesforukenglandandwalesscotlandandnorthernireland. Accessed January 13, 2021.
- Worldometer. Countries in the world by population (2021); 2021. Available from: https://www.worldometers.info/world-population/population-by-country/. Accessed January 25, 2021.
- Public Health England. How local global burden of disease data can help shift the focus for the NHS; 2021. Available from: https://publichealthmatters.blog.gov.uk/2018/10/25/how-local-global-burden-of-disease-data-can-help-shift-the-focus-for-the-nhs/. Accessed January 27, 2021.
- Laitinen A, Laatikainen L, Harkanen T, Koskinen S, Reunanen A, Aromaa A. Prevalence of major eye diseases and causes of visual impairment in the adult Finnish population: a nationwide population-based survey. Acta Ophthalmol. 2010;88(4):463–471. doi:10.1111/j.1755-3768.2009.01566.x
- Costin BR, Perry JD. Ocular adnexal infections. Curr Ophthalmol Rep. 2014;2(3):124–128. doi:10.1007/s40135-014-0045-5
- Orazi A, Foucar K, Knowles D, Weiss L. Neoplastic Hematopathology. 3rd ed. Philadelphia, USA: Lippincott Williams & Wilkins; 2013.
- Platnick J, Crum A, Soohoo S, Cedeño P, Johnson M. The globe: infection, inflammation, and systemic disease. Semin Ultrasound CT MR. 2011;32(1):38–50. doi:10.1053/j.sult.2010.12.003
- Vieira-Potter V, Karamichos D, Lee D. Ocular complications of diabetes and therapeutic approaches. Biomed Res Int. 2016;2016:1–14. doi:10.1155/2016/3801570
- Alrawashdeh HM. An overview of diabetic retinopathy. Obes Diabetes Res. 2020;1(1):1–3. doi:10.47275/2692-0964-104
- Smittenaar CR, Petersen KA, Stewart K, Moitt N. Cancer incidence and mortality projections in the UK until 2035. Br J Cancer. 2016;115(9):1147–1155. doi:10.1038/bjc.2016.304
- Jankowski R. What do hospital admission rates say about primary care? BMJ. 1999;319(7202):67–68. doi:10.1136/bmj.319.7202.67
- Health and Social Care Information Centre (HSCIC). Hospital episode statistics; 2021. Available from: http://content.digital.nhs.uk/hes. Accessed January 13, 2021.
- NHS Wales Informatics Service. Annual PEDW data tables; 2021. Available from: http://www.infoandstats.wales.nhs.uk/page.cfm?pid=41010&orgid=869. Accessed January 13, 2021.
- Naser A, Wang Q, Wong L, et al. Hospital admissions due to dysglycaemia and prescriptions of antidiabetic medications in England and Wales: an Ecological Study. Diabetes Ther. 2018;9(1):153–163. doi:10.1007/s13300-017-0349-1
- Tulloch J, Decraene V, Christley R, Radford A, Warner J, Vivancos R. Characteristics and patient pathways of Lyme disease patients: a retrospective analysis of hospital episode data in England and Wales (1998–2015). BMC Public Health. 2019;19(931):1–11. doi:10.1186/s12889-019-7245-8
- Hemmo SI, Naser AY, Alwafi H, et al. Hospital admissions due to ischemic heart diseases and prescriptions of cardiovascular diseases medications in England and Wales in the past two decades. Int J Environ Res Public Health. 2021;18(13):13. doi:10.3390/ijerph18137041
- Naser AYA, Alrawashdeh HM, Alwafi H, et al. Hospital admission trends due to viral infections characterised by skin and mucous membrane lesions in the past two decades in England and Wales: an Ecological Study. Int J Environ Res Public Health. 2021;18(21):11649. doi:10.3390/ijerph182111649
- Naser AY, Mansour MM, Alanazi AFR, et al. Hospital admission trends due to respiratory diseases in England and Wales between 1999 and 2019: an ecologic study. BMC Pulm Med. 2021;21(1):356. doi:10.1186/s12890-021-01736-8
- Alanazi AFR, Naser AY, Pakan P, et al. Trends of hospital admissions due to congenital anomalies in England and Wales between 1999 and 2019: an Ecological Study. Int J Environ Res Public Health. 2021;18:22. doi:10.3390/ijerph182211808
- ICD10DATA.com. ICD-10-CM codes › H00-H59 diseases of the eye and adnexa; 2021. Available from: https://www.icd10data.com/ICD10CM/Codes/H00-H59/H55-H57/H57-/H57.9. Accessed January 25, 2021.
- NHS Wales Informatics Service. Data quality status report: admitted patient care data set; 2021. Available from: http://www.infoandstats.wales.nhs.uk/Documents/869/APC%20DQ%20Status%20Report%202015-16-v1.pdf. Accessed January 13, 2021.
- World Data Atlas. The United Kingdom; 2021. Available from: https://knoema.com/atlas/United-Kingdom/topics/Demographics/Population. Accessed January 15, 2021.
- Public Health England. NHS Diabetic Eye Screening Programme: Information for Health Professionals; 2021.
- Brooke S. Eye health cannot be ignored; 2018. Available from: https://www.raconteur.net/healthcare/eye-health/national-eye-health-week/. Accessed February 19, 2021.
- The Royal National Institute of Blind People. The state of the nation eye health 2017: a year in review; 2021. Available from: https://www.rnib.org.uk/sites/default/files/APDF%20The%20State%20of%20the%20Nation%20%20Eye%20Health%202017%20A%20Year%20in%20Review.pdf. Accessed February 19, 2021.
- National Health Services. Hospital admitted patient care activity, 2015–16; 2016. Available from: https://webarchive.nationalarchives.gov.uk/20180328130140/http://digital.nhs.uk/catalogue/PUB22378. Accessed February 16, 2021.
- Minassian D, Reidy A. Future sight loss UK 2; 2009. Available from: https://www.rnib.org.uk/knowledge-and-research-hub/research-reports/general-research/future-sight-loss-uk-2. Accessed February 16, 2021.
- Quartilho A, Simkiss P, Zekite A, Xing W, Wormald R, Bunce C. Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013. Eye. 2016;30(4):602–607. doi:10.1038/eye.2015.288
- Cockerham K, Chan S. Thyroid eye disease. Neurol Clin. 2010;28(3):729–755. doi:10.1016/j.ncl.2010.03.010
- FlightforSight. Thyroid eye disease: what is it? 2015. Available from: https://www.fightforsight.org.uk/about-the-eye/a-z-eye-conditions/thyroid-eye-disease/. Accessed February 17, 2021.
- Madi H, Keller J. Increasing frequency of hospital admissions for retinal detachment and vitreo-retinal surgery in England 2000–2018. Eye. 2021;published online ahead of print:1–5.
- Meyer C, Holz F. Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab. Eye. 2011;25(6):661–672. doi:10.1038/eye.2011.66
- Sarireh FA, Alrawashdeh HM, Zubi KA, Salem KA. Intravitreal bevacizumab alone versus combined bevacizumab and macular grid laser photocoagulation in diffuse diabetic macular oedema. J Clin Diagn Res. 2020;14(11):NC05–NC09.
- Thomas M, Mousa S, Mousa S. Comparative effectiveness of aflibercept for the treatment of patients with neovascular age-related macular degeneration. Clin Ophthalmol. 2013;7:495–501. doi:10.2147/OPTH.S29974
- Chopra R, Preston G, Keenan T, et al. Intravitreal injections: past trends and future projections within a UK tertiary hospital. Eye. 2021:1–6. doi:10.1038/s41433-021-01646-3
- Kermani T, Schäfer V, Crowson C, et al. Increase in age at onset of giant cell arteritis: a population-based study. Ann Rheum Dis. 2010;69(4):780–781. doi:10.1136/ard.2009.111005
- Miller N, Arnold A. Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy. Eye. 2015;29(1):65–79. doi:10.1038/eye.2014.144
- Yousufuddin M, Young N. Aging and ischemic stroke. Aging. 2019;11(9):2542–2544. doi:10.18632/aging.101931
- Kazama S, Kazama J, Ando N. Eye diseases in women. Fukushima J Med Sci. 2019;65(2):30–36. doi:10.5387/fms.2019-01
- Zetterberg M. Age-related eye disease and gender. Maturitas. 2016;83:19–26. doi:10.1016/j.maturitas.2015.10.005
- Eisner A. Sex, eyes, and vision: male/female distinctions in ophthalmic disorders. Curr Eye Res. 2015;40(2):96–101. doi:10.3109/02713683.2014.975368